Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Pancreatic Neoplasms 153Carcinoma, Non-Small-Cell Lung 94Neoplasms 57Breast Neoplasms 50Urinary Bladder Neoplasms 47Neoplasm Metastasis 43Lung Neoplasms 41Ovarian Neoplasms 36Cholangiocarcinoma 31Lymphoma 20Sarcoma 19Gallbladder Neoplasms 19Fallopian Tube Neoplasms 19Lymphoma, Large B-Cell, Diffuse 18Biliary Tract Neoplasms 18Recurrence 15Lymphoma, Non-Hodgkin 15Adenocarcinoma 14Hodgkin Disease 13Carcinoma, Transitional Cell 13Bile Duct Neoplasms 13Carcinoma 12Colorectal Neoplasms 10Head and Neck Neoplasms 8Carcinoma, Renal Cell 8Urethral Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 7Carcinoma, Ovarian Epithelial 7Adenocarcinoma of Lung 7Uterine Cervical Neoplasms 6

Interventions

pembrolizumab 4Cisplatin 4Gemcitabine 3Carboplatin 3Docetaxel 2Bupropion 2tocilizumab 1tislelizumab 1spartalizumab 1infigratinib 1etoposide phosphate 1cc-486 1avelumab 1Zoledronic Acid 1Vorinostat 1Varenicline 1Tobacco Use Cessation Devices 1Radiotherapy, Intensity-Modulated 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Pilocarpine 1Oral Hygiene 1Nivolumab 1Nicotine Replacement Therapy 1Nicotine 1NVP-BKM120 1Ifosfamide 1Gene Expression Profiling 1Fluorouracil 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Nasopharyngeal Neoplasms × Gemcitabine × Clear all
NCT03924986 2025-01-31

RATIONALE-309

BeiGene

Phase 3 Completed
263 enrolled 19 charts
Head & Neck

Nasopharyngeal Neoplasms, Recurrence

NCT02611960 2023-07-13

Keynote-122

Merck Sharp & Dohme LLC

Phase 3 Completed
233 enrolled 21 charts
Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Nasopharyngeal Neoplasms

NCT00603915 2019-02-28

A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer

University Health Network, Toronto

Phase 2 Completed
20 enrolled 8 charts
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡